Zhong Ji Longevity Science Group Limited
HKEX:0767.HK
0.275 (HKD) • At close November 5, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 65.347 | 89.445 | 62.982 | 81.407 | 147.432 | 180.048 | 273.347 | 555.386 | 102.391 | 64.239 | 29.693 | 34.72 | 52.958 | 4.374 | 391.23 | 733.979 | 1,029.04 | 1,190.59 | 1,055.933 | 1,161.787 |
| Cost of Revenue
| 16.043 | 10.039 | 13.587 | 9.574 | 3.598 | 3.314 | 1.057 | 5.12 | 1.418 | 1.857 | 5.341 | 3.003 | 2.652 | 0.856 | 404.996 | 664.135 | 881.604 | 977.428 | 900.115 | 956.55 |
| Gross Profit
| 49.304 | 79.406 | 49.395 | 71.833 | 143.834 | 176.734 | 272.29 | 550.266 | 100.973 | 62.382 | 24.352 | 31.717 | 50.306 | 3.518 | -13.765 | 69.844 | 147.436 | 213.162 | 155.818 | 205.237 |
| Gross Profit Ratio
| 0.754 | 0.888 | 0.784 | 0.882 | 0.976 | 0.982 | 0.996 | 0.991 | 0.986 | 0.971 | 0.82 | 0.914 | 0.95 | 0.804 | -0.035 | 0.095 | 0.143 | 0.179 | 0.148 | 0.177 |
| Reseach & Development Expenses
| 0 | 0 | 0 | -0 | -0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 69.535 | 41.114 | 43.746 | 28.819 | 46.403 | 97.915 | 135.076 | 147.473 | 69.48 | 32.637 | 32.98 | 27.141 | 18.446 | 10.398 | 53.068 | 69.092 | 79.601 | 79.351 | 83.711 | 80.132 |
| Selling & Marketing Expenses
| 5.714 | 2.842 | 2.752 | 5.556 | 6.241 | 0 | 0.14 | 15.03 | 9.943 | 0 | 0 | 0 | 3.692 | 1.362 | 37.132 | 87.227 | 0 | 0 | 0 | 0 |
| SG&A
| 75.249 | 43.965 | 46.507 | 34.375 | 46.403 | 97.915 | 135.216 | 162.503 | 79.423 | 32.637 | 32.98 | 27.141 | 22.138 | 11.76 | 90.2 | 156.319 | 79.601 | 79.351 | 83.711 | 80.132 |
| Other Expenses
| -43.614 | -78.698 | -59.111 | -85.736 | -970.46 | -150.249 | -134.159 | -160.105 | -66.733 | 0 | 0 | -3.684 | -0.419 | -3.627 | -4.312 | -13.911 | 90.713 | 109.361 | 107.165 | 159.961 |
| Operating Expenses
| 43.614 | 78.698 | 59.111 | 85.736 | 970.46 | 2,359.101 | 144.679 | 133.032 | 246.266 | 84.261 | 32.98 | 23.457 | 21.719 | 8.133 | 85.888 | 142.408 | 170.315 | 188.712 | 190.875 | 240.093 |
| Operating Income
| 5.69 | 0.708 | -9.716 | -13.903 | -826.626 | 26.347 | 138.131 | 390.161 | 21.55 | 30.611 | 74.603 | 10.714 | 199.487 | -14.523 | -101.801 | -74.075 | -22.879 | 24.449 | -35.057 | -34.856 |
| Operating Income Ratio
| 0.087 | 0.008 | -0.154 | -0.171 | -5.607 | 0.146 | 0.505 | 0.703 | 0.21 | 0.477 | 2.512 | 0.309 | 3.767 | -3.32 | -0.26 | -0.101 | -0.022 | 0.021 | -0.033 | -0.03 |
| Total Other Income Expenses Net
| -0.866 | 10.243 | 15.776 | 5.884 | 13.154 | -2,205.4 | -9.463 | 32.193 | -165.425 | -50.633 | 67.742 | 51.553 | -341.8 | 19.815 | -16.937 | -31.163 | 18.723 | -20.888 | -28.1 | -22.859 |
| Income Before Tax
| 4.824 | 10.951 | 6.06 | -8.019 | -813.472 | -2,179.053 | 128.668 | 422.354 | -143.875 | -20.022 | 74.507 | 62.267 | -142.313 | 5.292 | -118.739 | -105.238 | -4.156 | 3.562 | -63.157 | -57.716 |
| Income Before Tax Ratio
| 0.074 | 0.122 | 0.096 | -0.099 | -5.518 | -12.103 | 0.471 | 0.76 | -1.405 | -0.312 | 2.509 | 1.793 | -2.687 | 1.21 | -0.304 | -0.143 | -0.004 | 0.003 | -0.06 | -0.05 |
| Income Tax Expense
| 2.222 | 8.622 | 0.76 | 1.528 | 13.54 | 17.544 | 41.219 | 89.29 | 5.963 | 6.899 | -68.928 | -0.012 | 2.646 | 0.148 | -42.785 | 180.6 | -14.044 | 20.888 | -1.854 | -22.758 |
| Net Income
| 2.313 | -0.904 | 6.055 | -11.487 | -825.678 | -2,199.094 | 82.274 | 321.907 | -148.282 | -26.008 | 75.597 | 62.283 | -134.081 | 75.998 | -75.954 | -282.506 | 9.888 | 3.562 | -61.303 | -34.957 |
| Net Income Ratio
| 0.035 | -0.01 | 0.096 | -0.141 | -5.6 | -12.214 | 0.301 | 0.58 | -1.448 | -0.405 | 2.546 | 1.794 | -2.532 | 17.375 | -0.194 | -0.385 | 0.01 | 0.003 | -0.058 | -0.03 |
| EPS
| 0.002 | -0.001 | 0.004 | -0.008 | -2.13 | -5.68 | 0.056 | 0.22 | -0.53 | -0.094 | 0.061 | 0.22 | -7.93 | 67.48 | -31.4 | -116.77 | 4.46 | 1.75 | -60.45 | -34.12 |
| EPS Diluted
| 0.002 | -0.001 | 0.004 | -0.008 | -2.13 | -5.68 | 0.056 | 0.22 | -0.53 | -0.094 | 0.061 | 0.22 | -7.93 | 67.48 | -31.4 | -116.77 | 4.46 | 1.75 | -60.45 | -34.12 |
| EBITDA
| 13.024 | 4.916 | -5.339 | -11.893 | -823.028 | -2,207.897 | -14.638 | 21.036 | -163.869 | -49.72 | 7.975 | 11.627 | 199.527 | 34.843 | -44.856 | -5.076 | 47.427 | 97.626 | 37.811 | 40.963 |
| EBITDA Ratio
| 0.199 | 0.055 | -0.085 | -0.146 | -5.582 | -12.263 | -0.054 | 0.038 | -1.6 | -0.774 | 0.269 | 0.335 | 3.768 | 7.966 | -0.115 | -0.007 | 0.046 | 0.082 | 0.036 | 0.035 |